Company Overview and News

Brio Gold Obtains Final Order for Arrangement With Leagold Mining Corporation

2018-04-17 globenewswire
TORONTO, April 17, 2018 (GLOBE NEWSWIRE) -- BRIO GOLD INC. (TSX:BRIO) (“BRIO GOLD” or the “Company”) is pleased to announce that it has obtained a final order from the Ontario Superior Court of Justice (Commercial List) approving its previously announced plan of arrangement (the “Arrangement”) with Leagold Mining Corporation (“Leagold”), whereby Leagold will acquire all of the issued and outstanding shares of Brio Gold pursuant to an arrangement agreement dated February 15, 2018.
Upvote Downvote

Brio Gold Shareholders Approve Acquisition by Leagold Mining Corporation

2018-04-12 globenewswire
TORONTO, April 12, 2018 (GLOBE NEWSWIRE) -- BRIO GOLD INC. (“BRIO GOLD” or the “Company”) (TSX:BRIO) herein announces the voting results from the Company's Special Meeting held on April 12, 2018 (the "Meeting"). At the Meeting, shareholders of the Company were asked to consider and, if deemed advisable, to approve a special resolution (the “Arrangement Resolution”) authorizing the proposed plan of arrangement (the “Arrangement”) of Brio Gold under section 182 of the Business Corporations Act (Ontario), whereby Leagold Mining Corporation will acquire all of the issued and outstanding shares of Brio Gold pursuant to an arrangement agreement dated February 15, 2018.
Upvote Downvote

Yamana Gold - Just A 'Gualcamayo' Too Short

2018-02-21 seekingalpha
The 2017 results, while impressive, scared the market. The stock sold off on the news that the company took a $356 million non-cash impairment charge mainly relating to Gualcamayo mine.
Upvote Downvote

Brio Gold Agrees to Increased Offer from Leagold

2018-02-16 marketwired
TORONTO, ON--(Marketwired - February 16, 2018) - Brio Gold Inc. ("Brio Gold") (TSX: BRIO) is pleased to announce that it has entered into a definitive agreement (the "Arrangement Agreement") pursuant to which Leagold Mining Corporation ("Leagold") will acquire all of the issued and outstanding shares of Brio Gold (the "Transaction"), based on an increased value for Brio Gold shareholders. The combined company will be a high-growth, intermediate gold producer, having four operating mines and an advanced-stage development project, which are located in Mexico and Brazil, two attractive mining jurisdictions in the Americas.
Upvote Downvote

HTXFF / Leagold Mining Corp. 425 (Prospectus)

  Filed by Leagold Mining Corporation Pursuant to Rule 425 under the Securities Act of 1933, as amended Subject Company: Brio Gold Inc. A registration statement is expected to be filed by Leagold Mining Corporation   The following is a transcript of an interview given by Neil Woodyer, Chief Executive Officer of Leagold Mining Corporation, which took place on January 26, 2018, a recording of which is available on BNN Business News’ website at www.
Upvote Downvote

Yamana Gold - Leagold To Make An Offer To Acquire Brio Gold

2018-01-24 seekingalpha
Leagold Mining is offering 57% premium to Brio Gold shareholders in an all-share deal. The all-stock offer results in Brio shareholders owning approximately 42% of the combined company.
Upvote Downvote

Small remains beautiful for gold mining acquisitions

2018-01-24 reuters
VANCOUVER (Reuters) - Small, opportunistic deals will dominate the global gold mining sector again this year, analysts said on Tuesday, after Leagold Mining Corp unveiled a $264 million bid for fellow Canadian gold miner Brio Gold Inc.
Upvote Downvote

Brio Gold Responds to Announcement by Leagold

2018-01-23 marketwired
TORONTO, ON--(Marketwired - January 23, 2018) - BRIO GOLD INC. (TSX: BRIO) ("BRIO GOLD" or the "Company") today responded to the announcement by Leagold Mining Corporation ("Leagold") that it intends to make an offer to acquire all of the outstanding shares of Brio Gold.
Upvote Downvote

BRIEF-Leagold Mining Intends To Make Offer To Acquire All Of Issued, Outstanding Shares Of Brio Gold

2018-01-23 reuters
Upvote Downvote

BRIEF-Leagold Mining Q4 2017 Los Filos Mine Production Of 53,446 Oz

2018-01-04 reuters
Upvote Downvote

Top 20 Gold Mining Stocks For 2018

2018-01-02 seekingalpha
Above are my Top 20 gold mining stocks for 2018. All of these companies have large resources and are highly undervalued based on their cash flow potential at higher gold prices. They are on this list primarily because of their upside potential. These are either producers or development stocks, although there is one optionality play (Goldmining Inc).
Upvote Downvote


2017-10-11 reuters
Upvote Downvote

BRIEF-Leagold Mining Corp reports Q2 adjusted earnings per share ‍$0.06​

2017-08-10 reuters
* Leagold reports Q2 2017 aisc/oz of $989 and all-in sustaining cost margin of $13.8 million
Upvote Downvote

Timmins Gold: The Sum Of Its Parts

2017-05-09 seekingalpha
Timmins Gold is undergoing a transformation with a planned name change and new senior management in place.
Upvote Downvote

LeaGold Mining: A Mid-Tier Producer Flying Under The Radar

2017-05-02 seekingalpha
LeaGold Mining purchased Goldcorp's Los Filos Mine in Guerrero, Mexico and has made the project its flagship asset.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...